Emily Leproust Insider Trades & Stock Holdings
Emily Leproust, Chief Executive Officer at Twist Bioscience Corporation has 2 Form 4 trades on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($1.94M), net -$1.94M. Latest filing: disposed of 18.88K shares of $TWST on Jun 25, 2026 at $95.
- Trades on file
- 2
- Open-market bought
- $0
- Open-market sold
- $1.94M
- Net open-market
- -$1.94M
- Latest filing
- Jun 25, 2026
All insider trades by Emily Leproust
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $TWST | Sell (Open-market sale) 10b5-1 | 18.88K | $95 | $1.79M | +2.7% | -10.5% | Chief Executive Officer | — | |||||
| $TWST | Sell (Open-market sale) | 1.69K | $87.32 | $147.40K | +15.5% | +10.6% | Chief Executive Officer | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Emily Leproust traded
Frequently asked questions
Has Emily Leproust been buying or selling stock?
Emily Leproust has 0 open-market purchases and 2 open-market sales on file, net -$1.94M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Emily Leproust's latest insider trade?
disposed of 18.88K shares of $TWST on Jun 25, 2026 at $95.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.